Collapsed Alveoli Causes Poor Blood Oxygenation, Respiratory Distress (IMAGE) Purdue University Caption Spirrow Therapeutics, a Purdue University-related startup, is developing a novel treatment for a life-threatening lung condition known as acute respiratory distress syndrome, or ARDS. The treatment uses a nanoparticle to mimic the behavior of a natural surfactant in the lungs to work within the lungs' processes for inflation and oxygenation. Credit Davis Arick, Spirrow Therapeutics Usage Restrictions None License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.